Fortress Biotech, Inc.: shareholders and insiders

FBIONASDAQHealthcare · Pharmaceutical Preparations

Price

$1.82

November 17, 2026Market cap $57M

What Ploutos Investor adds for Fortress Biotech

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 13 fiscal years, from 2013
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
  • A figure that did not match the numbers it is built from has been left out.

Insiders and their shares

Purchases and sales by officers and directors from Nov 18, 2025 to Oct 1, 2026, from their own Form 4 filings.

2 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Oct 1, 2026David JinChief Financial Officer
    Kind
  • Jun 22, 2026David JinChief Financial Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by FBIO's officers and directors from 2011 up to November 17, 2025, 15 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DOct 29, 2026 Latest filing
  • Lindsay A. Rosenwald, M.D.
    Share of class20.7%
  • Highbridge Capital Management, LLC
    Share of class7.80%
  • Integrated Core Strategies (US) LLCwith 3 more persons
    Share of class6.50%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Lindsay A. Rosenwald, M.D.20.7%From the filing of Mar 20, 2026

    The Reporting Person was granted the shares of Common Stock on each of January 1, 2025 and March 18, 2026 pursuant to the LTIP and Award Agreement and upon the determination that the Reporting Person had achieved 100% of the relevant goals and objectives established by the Compensation Committee of the Issuer's Board. The Reporting Person does not have any present plans or proposals that relate to or would result in: (i) the acquisition by any person of additional securities of Issuer, or the disposition of securities of Issuer; (ii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving Issuer or any of Issuer's subsidiaries; (iii) a sale or…

    From the filing of Mar 20, 2026

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-57%
  • Renaissance Technologies
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 14.4% of its shares outstanding were held short, -7.7% since the report before.

Shares held short
4.52M
14.4%
Since the report before4.90M on Sep 30, 2026
-7.7%
16.1
281.0K
More days to cover thanof 4,578 US-listed companies with enough volume
98%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 169.9K
  • Nov 15, 2023: Shares held short 259.8K
  • Nov 30, 2023: Shares held short 618.0K
  • Dec 15, 2023: Shares held short 907.4K
  • Dec 29, 2023: Shares held short 1.13M
  • Jan 12, 2024: Shares held short 1.29M
  • Jan 31, 2024: Shares held short 1.49M
  • Feb 15, 2024: Shares held short 1.64M
  • Feb 29, 2024: Shares held short 1.54M
  • Mar 15, 2024: Shares held short 1.73M
  • Mar 28, 2024: Shares held short 1.88M
  • Apr 15, 2024: Shares held short 1.82M
  • Apr 30, 2024: Shares held short 1.75M
  • May 15, 2024: Shares held short 1.67M
  • May 31, 2024: Shares held short 1.61M
  • Jun 14, 2024: Shares held short 1.54M
  • Jun 28, 2024: Shares held short 1.66M
  • Jul 15, 2024: Shares held short 1.48M
  • Jul 31, 2024: Shares held short 1.59M
  • Aug 15, 2024: Shares held short 1.61M
  • Aug 30, 2024: Shares held short 1.72M
  • Sep 13, 2024: Shares held short 2.17M
  • Sep 30, 2024: Shares held short 2.35M
  • Oct 15, 2024: Shares held short 2.57M
  • Oct 31, 2024: Shares held short 2.62M
  • Nov 15, 2024: Shares held short 2.92M
  • Nov 29, 2024: Shares held short 2.82M
  • Dec 13, 2024: Shares held short 3.11M
  • Dec 31, 2024: Shares held short 3.40M
  • Jan 15, 2025: Shares held short 3.48M
  • Jan 31, 2025: Shares held short 3.58M
  • Feb 14, 2025: Shares held short 3.69M
  • Feb 28, 2025: Shares held short 3.68M
  • Mar 14, 2025: Shares held short 3.77M
  • Mar 31, 2025: Shares held short 3.63M
  • Apr 15, 2025: Shares held short 3.63M
  • Apr 30, 2025: Shares held short 3.69M
  • May 15, 2025: Shares held short 3.51M
  • May 30, 2025: Shares held short 3.36M
  • Jun 13, 2025: Shares held short 3.29M
  • Jun 30, 2025: Shares held short 3.20M
  • Jul 15, 2025: Shares held short 3.13M
  • Jul 31, 2025: Shares held short 2.98M
  • Aug 15, 2025: Shares held short 2.79M
  • Aug 29, 2025: Shares held short 3.03M
  • Sep 15, 2025: Shares held short 3.79M
  • Sep 30, 2025: Shares held short 3.75M
  • Oct 15, 2025: Shares held short 3.38M
  • Oct 31, 2025: Shares held short 3.51M
  • Nov 14, 2025: Shares held short 3.98M
  • Nov 28, 2025: Shares held short 3.71M
  • Dec 15, 2025: Shares held short 3.62M
  • Dec 31, 2025: Shares held short 4.05M
  • Jan 15, 2026: Shares held short 4.49M
  • Jan 30, 2026: Shares held short 4.58M
  • Feb 13, 2026: Shares held short 4.31M
  • Feb 27, 2026: Shares held short 4.48M
  • Mar 13, 2026: Shares held short 4.28M
  • Mar 31, 2026: Shares held short 4.36M
  • Apr 15, 2026: Shares held short 4.55M
  • Apr 30, 2026: Shares held short 4.65M
  • May 15, 2026: Shares held short 4.88M
  • May 29, 2026: Shares held short 5.09M
  • Jun 15, 2026: Shares held short 5.14M
  • Jun 30, 2026: Shares held short 5.31M
  • Jul 15, 2026: Shares held short 5.38M
  • Jul 31, 2026: Shares held short 5.78M
  • Aug 14, 2026: Shares held short 5.58M
  • Aug 31, 2026: Shares held short 5.44M
  • Sep 15, 2026: Shares held short 5.11M
  • Sep 30, 2026: Shares held short 4.90M
  • Oct 15, 2026: Shares held short 4.52M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading56.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 56.7% of the shares in the reported trades were short sales, against 35.4% in the 14 before.

Last 14 sessionsOct 29, 2026 – Nov 17, 2026
56.7%
The 14 beforeOct 9, 2026 – Oct 28, 2026
35.4%
Change
+21.3 pts
Short sales a dayon average, of 141.6K shares
80.3K
More than atof 3,666 US-listed companies, same days
73%
Median of alleight in ten from 34.6% to 63.7%
50.3%
  • Oct 9, 2026: Short sales 22.1%
  • Oct 12, 2026: Short sales 29.6%
  • Oct 13, 2026: Short sales 35.8%
  • Oct 14, 2026: Short sales 24.1%
  • Oct 15, 2026: Short sales 32.7%
  • Oct 16, 2026: Short sales 36.3%
  • Oct 19, 2026: Short sales 73.6%
  • Oct 20, 2026: Short sales 25.6%
  • Oct 21, 2026: Short sales 36.5%
  • Oct 22, 2026: Short sales 27.2%
  • Oct 23, 2026: Short sales 40.6%
  • Oct 26, 2026: Short sales 48.4%
  • Oct 27, 2026: Short sales 36.9%
  • Oct 28, 2026: Short sales 30%
  • Oct 29, 2026: Short sales 61.4%
  • Oct 30, 2026: Short sales 52.9%
  • Nov 2, 2026: Short sales 53.5%
  • Nov 3, 2026: Short sales 37.2%
  • Nov 4, 2026: Short sales 41.9%
  • Nov 5, 2026: Short sales 59.1%
  • Nov 6, 2026: Short sales 33.5%
  • Nov 9, 2026: Short sales 59.1%
  • Nov 10, 2026: Short sales 50.9%
  • Nov 11, 2026: Short sales 82.7%
  • Nov 12, 2026: Short sales 52.2%
  • Nov 13, 2026: Short sales 41.5%
  • Nov 16, 2026: Short sales 58.4%
  • Nov 17, 2026: Short sales 54.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

5.36M Insiders' shares6.84% Of the company
  • Lindsay A Md RosenwaldPRESIDENT, CEO & CHAIRMAN
    Directly3.66M
  • David JinChief Financial Officer
    Directly1.65M
  • Dov KleinDirector
    Directly53.4K

A lower bound: it counts only the 3 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

55 Managers, Q2 2026$18M Value of their positions
  • Q3 2025: Managers 56
  • Q4 2025: Managers 52
  • Q1 2026: Managers 53
  • Q2 2026: Managers 55

Institutional investors by quarter

The fund managers holding FBIO, quarter by quarter, from Q1 2015 to Q2 2025, 42 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 55 managers held 5.84M shares, worth $18M. During the quarter 13 opened a position, 11 closed one, 12 added and 18 trimmed.

The largest holders, Q2 2026

  • Vanguard Capital Management
    In the quarter+7.4%
  • Opaleye Management
    In the quarter-15%
  • Mackenzie Financial
    In the quarter
  • Gsa Capital Partners
    In the quarter+80%
  • Shikiar Asset Management
    In the quarter
  • Geode Capital Management
    In the quarter+3.5%
  • BlackRock
    In the quarter+14%
  • Two Sigma Investments
    In the quarter+8.6%
  • Bridgeway Capital Management
    In the quarter-2.7%
  • Vanguard Fiduciary Trust
    In the quarter+17%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Fortress Biotech's filings show?

Who buys and sells is one part of Fortress Biotech's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about FBIO's shareholders

Didn't find what you were looking for?

Ask us
Have FBIO's insiders bought or sold?

From Jun 24, 2026 to Oct 1, 2026 Fortress Biotech's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold FBIO?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $200.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.